17th International Pharmacovigilance Europe Conference
19 to 20 May 2027Hilton London Olympia12 CPD hours
The 17th edition of Pharmacovigilance Europe brings senior decision-makers together to share knowledge, shape the future and drive better patient outcomes.
100+
Senior PV leaders
12
CPD hours
10+ hrs
Networking
17th
Edition
The people who make progress happen
Regulators, pharma and biotech leaders who speak at and attend Pharmacovigilance Europe, from 40+ countries.
One room, every perspective
Make the most of your time
Choose the experience that fits your goals, whether you are here to learn, exhibit, speak or build new partnerships.
Access inspiring sessions, expert panels and industry insights.
Showcase your solutions, meet qualified leads and build lasting partnerships.
Increase your visibility, position your brand and achieve your business goals.
Connect with peers, build relationships and explore new opportunities.
Hear from global experts and gain practical insights for what is next.
Arrange one-to-one meetings and find the right partners for your goals.
The opportunity ahead
As the global pharmacovigilance market grows, the people responsible for patient safety need trusted spaces to share what works.
US$8.6bn
Global market in 2025
US$13.5bn
Projected by 2033
5.6%
Expected CAGR, 2026 to 2033
Source: Grand View Research, Pharmacovigilance Market Report
2014
first edition, 17th in 2027
senior PV leaders
40+
countries represented
of dedicated networking
Live registrations
Drug safety leaders across Europe and North America are already booking their place in London.
Showing country and time only. We never display delegate names.
The people shaping the conversation
Conference Chair
Chief Safety Officer, MHRA
VP, Global Head of Pharmacovigilance, Opella
Global Head, International Patient Safety, Roche
Head of International Patient Safety, Bristol Myers Squibb
Senior Director, Regulatory Compliance, Johnson & Johnson
Built for the people doing the work
Meet senior professionals and decision-makers across the life-sciences community, from pharma and biotech to CROs and solution providers.
Be part of the room
Put your organisation in front of the people making decisions across pharmacovigilance, safety and regulatory affairs.
Sponsors, exhibitors and partners who have supported us
The value of being there
Meet the right people and take the next conversation home.
Build useful relationships with decision-makers from more than 40 countries.
Why it matters
Focused, useful networking.
Ten or more hours of dedicated networking make it easier to meet peers facing similar challenges.
Delegate experience
More than a programme
Hear how senior teams are handling the decisions that shape modern drug safety.
Bring current thinking on signal management, inspections and risk management back to your team.
Use focused sessions, exhibitions and partner meetings to move conversations forward.
Delegate passes
Two-day delegate pass for Pharmacovigilance Europe 2027 at the Hilton London Olympia, with 12 CPD hours. Prices shown exclude VAT, which is added at 20%.
Special Offer
£999 + VAT
£1,198.80 incl. VAT (VAT £199.80)
First 15 passes only, until 15 November 2026 · save £1,100
Super Early Bird
£1,099 + VAT
£1,318.80 incl. VAT (VAT £219.80)
Available now until 31 January 2027
Early Bird
£1,499 + VAT
£1,798.80 incl. VAT (VAT £299.80)
1 February to 14 April 2027
Standard
£2,099 + VAT
£2,518.80 incl. VAT (VAT £419.80)
From 15 April 2027
Hilton London Olympia · 19 to 20 May 2027
Two focused days with senior drug safety and regulatory leaders in London.
Make two days count.